Tom Needham - Profile and Investment Details

Investor Profile

Tom Needham is a Venture Capital, Investor, Private Equity Firm based in Boston, Massachusetts, United States with a diverse investment portfolio that includes companies such as FineHeart, Provasculon, Laurantis Pharma, DecImmune Therapeutics, Gila Therapeutics, Herantis Pharma, Aria CV, Remedy Pharmaceuticals, Apama Medical, CroíValve, ZZ Biotech, Adient Medical, HAYA Therapeutics, Intravascular Imaging Incorporated, NIDO, G.I. Windows, NuPulseCV, 480 Biomedical, Cardero Therapeutics, Epirium Bio, Allosteros, AtaCor Medical, Alleviant Medical, CardiaLen, Aggamin Biologics, Mellitus, Basking Biosciences, InfoBionic, Vectorious Medical Technologies, Ischemia Care, Capricor Therapeutics, CellAegis Devices, Renovacor, Vascular Graft Solutions, CardiAQ Valve Technologies, Antag Therapeutics, Ventrinova, Pulmokine, BioKier, Zumbro Discovery, Viridian Therapeutics, Acesion Pharma, Aeromics. Over time, Tom Needham has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Tom Needham is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Women Founded, HR Tech, Android, Life Science, Biotech, Medical Device, Healthcare, Biotechnology, Consumer Health, Health and Hospital Services, Clinical Trials, Health IT, Digital Health, Medical, Therapeutics, Media and Entertainment, Pharmaceuticals, Biopharma may find it worthwhile to explore potential connections with Tom Needham, as their portfolio suggests a familiarity and interest in this area.

Understanding Tom Needham’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.